LIMINATUS PHARMA, INC. (LIMN)
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
Arcos Dorados Reports Second Quarter 2026 Financial Results
Caliber Goes Live with PURE Pickleball & Padel Tokenized Real Estate Investment Offering
Financial Statements and Related Announcement: Half Yearly Results
Financial Statements and Related Announcement: Half Yearly Results (2026)
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
Change - Announcement of Cessation: Cessation of Group Chief Operating Officer
Change - Announcement of Appointment: Appointment of Group Chief Operating Officer
General Announcement: Appointment of Group Chief Operating Officer
Charlotte's Web Reports Second Quarter 2026 Financial Results